UK investigates pancreas risks linked to weight loss and diabetes jabs
A study has been launched to investigate serious side effects, including pancreatitis, linked to weight loss drugs like Mounjaro, Ozempic, and Wegovy, after reports of hospitalizations and deaths. The research aims to identify genetic risk factors to improve safety and reduce adverse reactions, with data collection through the MHRA's Yellow Card scheme and saliva samples from affected patients.